Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Alnylam Pharmaceuticals, Inc. operates as biopharmaceutical company, which engages in the discovery, development and commercialization of RNAi therapeutics. It is the translation of RNAi as a new ...
Sarah Burris is a long-time veteran of political campaigns, having worked as a fundraiser and media director across the United States. She transitioned into reporting while working for Rock the ...
Collegium Pharmaceutical, Inc. is a pharmaceutical company, which engages in development and planning to commercialize next generation, abuse-deterrent products for the treatment of patients ...
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. The company offers Basaglar, Humalog, Humalog Mix 75/ ...
Tonix Pharmaceuticals (NASDAQ:TNXP) was able to have its New Drug Application of TNX-102 SL for the treatment of patients with Fibromyalgia accepted by the FDA. Not only was this regulatory ...
Trump hints at next round of tariffs Exact timing and scope of the tariff implementation remains unclearFinance Minister Paschal Donohoe calls tariffs ‘a very serious economic challenge’Simon ...
The pharmaceutical construction industry has seen explosive growth, a trend with substantial implications for healthcare industry, and global health outcomes. The COVID-19 pandemic underscored the ...
Explore Syros Pharmaceuticals stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for SYRS. US Stocks Likely To Open Higher As Wall Street Watches Trump Tariff ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results